.webp?width=100&height=76&name=icons%20(1).webp)
.webp?width=100&height=76&name=Layer_1%20(1).webp)
.webp?width=100&height=76&name=Layer_1%20(2).webp)
.webp?width=100&height=76&name=Vector%20(2).webp)
.png?width=100&height=76&name=Layer_1%20(1).png)
.webp?width=100&height=76&name=Layer_1%20(4).webp)
.webp?width=100&height=76&name=Layer_1%20(3).webp)
-1.webp?width=100&height=76&name=Layer_1%20(2)-1.webp)
March 23-26, 2026
New York City
Adapted to your program
Our methodology tailors process design, control strategy, and capacity to your orphan program’s reality.
.png?width=280&height=150&name=Mask%20group%20(2).png)
Define Product Requirements
Align the target product profile and packaging format that drives execution.
Build the process and controls
Design a dedicated process and define the control strategy for consistent performance.
.webp?width=280&height=150&name=Mask%20group%20(1).webp)
Lock analytical readiness
Set specifications and validate fit‑for‑purpose methods to support release and stability.
Execute GMP manufacturing
Run GMP batches with in‑process controls, documentation readiness, and integrated packaging execution.
Sustain routine supply
Prepare validation readiness and manage lifecycle changes to keep supply consistent over time.
Our Capabilities
Designed for small‑volume programs, with end‑to‑end control from development through GMP production.
Adapted to evolving programs
Orphan drug products evolve quickly. We translate it into a production-ready process, with a defined control strategy and documentation to support scale‑up and supply.
-
We formalize process knowledge and batch records to support smooth progression into GMP manufacture.
-
We define critical process parameters and in‑process controls to keep performance consistent across phases.
.webp?width=524&height=297&name=Frame%202354%20(15).webp)
Release control from clinical to supply
Orphan drug products require consistent, defensible release. We define methods, strategy, and stability execution to maintain control from clinical to routine supply.
-
We align analytical strategy with product risks, phase needs, and GMP release requirements.
-
We generate stability data and maintain controlled updates to keep supply consistent over time.
Our Services
Designed for rare disease programs, combining development, analytical readiness, and GMP small‑batch manufacturing.
-1.svg)
-2.svg)
-1.svg)
Manufacturing & Packaging
Small-batch GMP manufacturing with integrated packaging execution.